
Dominic Morley
Head of Corporate Advisory
EmailFinding the right funding solution for a company at the right time is a key element of our 21st century merchant banking approach.
A company that endeavours to raise capital to deliver on its strategy may find the best solution is to raise public equity, either through an initial public offering or with follow-on equity for a company that already has a public listing. We raise equity for growth and mid-cap companies, both public and private, at different stages of development and for a range of purposes.
We have more experience than most: we first raised equity for a client more than 140 years ago.
Our corporate advisory and broking team supports capital raisings across our sectors by working closely with research analysts who are experts in their fields and with our sales and equity execution teams who have a deep understanding of what equity investors look for.
JULY 2018
Allergy Therapeutics plc
Secondary Offering
Financial Adviser, Nominated Adviser and Broker
£11 million
MAR 2018
Summit Therapeutics plc
Secondary Offering
Joint Broker and Joint Bookrunner
£15 million
FEB 2018
Faron Pharmaceuticals Ov
Secondary Offering
Financial Adviser, Broker and Sole Bookrunner
£15 million
NOV 2017
Keystone Law Group plc
Initial Public Offering raising £15M
Nominated Advisor and Broker
£50 million
OCT 2017
Hutchinson China MediTech Ltd
Secondary Offering
C0-Manager
$301 million
JUN 2017
Eland Oil & Gas plc
Secondary Offering
Lead Bookrunner
$20 million
“I would have no hesitation in recommending Panmure Gordon to any other business contemplating an IPO.”
Quiz Founder & CEO, Tarak Ramzan